BIIB Biogen
$249.59 +1.00%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
+1.00%
YTD
+41.80%
P/E
106.9
P/B
1.41
ROE
1.9%
Div yield
—
Beta
0.35
Market cap
$37.1B
RSI (14)
54
Next earnings
Feb 4, 2027
Same sector · Health Care
Compare BIIB with NVO and JNJ →Follow BIIB in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$248.74
Close
$249.59
Day high
$253.00
Day low
$248.04
Volume
1.1M
Latest headlines
Are Wall Street Analysts Predicting Biogen Stock Will Climb or Sink?
Yahoo Finance · Nov 20
Clarity AD CSF Substudy Findings on Lecanemab Treatment and α-Synuclein Co-Pathology Presented at CTAD 2026
Yahoo Finance · Nov 19
Should Biogen Stock Holders Look At Amgen Instead?
Yahoo Finance · Nov 19
Biogen reports two-year Phase II data for diranersen in Alzheimer’s
Yahoo Finance · Nov 19
What Could Biogen (BIIB) Gain From Its New Protein Degrader Research Deal?
Yahoo Finance · Nov 19
New Three-Year Real-World LEQEMBI® Data Presented at CTAD 2026
Yahoo Finance · Nov 18
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Oct 28, 2026 View → 8-K Oct 28, 2026 View → 10-Q Jul 29, 2026 View → 8-K Jul 29, 2026 View → 8-K Jul 1, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell BIIB. Try it in the Lab to size a position and see the risk.